Nucleofill Strong is an advanced polynucleotide skin booster formulated to improve skin quality through hydration, bio-stimulation, and tissue support. Featuring a concentrated 25 mg/ml polynucleotide gel, it is intended for patients presenting with more advanced signs of skin ageing, loss of elasticity, and environmental skin damage.
The product is widely incorporated into professional aesthetic treatment plans targeting facial rejuvenation, skin firmness enhancement, and regenerative skin therapy. Unlike volumising fillers, Nucleofill Strong focuses on improving tissue quality and supporting natural biological processes within the skin.
Practitioners researching Nucleofill Strong, Nucleofill 25 polynucleotide, buy Nucleofill Strong, or buy Nucleofill 25 often select this formulation when stronger bio-restructuring support is desired.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesNucleofill 25, commonly marketed as Nucleofill Strong, is a high-concentration polynucleotide-based injectable medical device developed by Promoitalia Medical Aesthetics. Designed for advanced skin bio-restructuring and tissue regeneration, it contains highly purified polynucleotides at a concentration of 25 mg/ml (2.5%), making it the strongest formulation within the Nucleofill range.
The product functions through multiple biological mechanisms. Polynucleotides provide intensive hydration through water-binding activity, support fibroblast stimulation, promote extracellular matrix regeneration, and contribute antioxidant protection against free radical damage. These combined effects aim to improve skin elasticity, firmness, texture, and overall tissue quality.
Nucleofill Strong is generally indicated for mature skin, significant skin laxity, photoaged skin, and areas requiring enhanced regenerative support. It is frequently selected by practitioners seeking a more intensive polynucleotide treatment compared with lower-concentration formulations such as Nucleofill Medium.
Nucleofill Strong belongs to the growing category of regenerative injectable treatments, alongside products such as Nucleofill Medium, Plenhyage XL Strong, and Profhilo®.
Compared with Nucleofill Medium, Nucleofill Strong contains a higher concentration of polynucleotides (25 mg/ml versus 20 mg/ml), providing greater viscosity and a stronger regenerative profile intended for patients with more advanced skin ageing concerns.
Profhilo®, by contrast, is based on stabilised hyaluronic acid and primarily focuses on hydration and tissue remodelling. While both products aim to improve skin quality, Nucleofill Strong relies on polynucleotide-mediated fibroblast activation and antioxidant activity rather than hyaluronic acid bio-remodelling.
Similarly, other polynucleotide products may share regenerative goals, but formulation concentration, molecular characteristics, and treatment indications differ between manufacturers.
This comparison is provided for clinical orientation only and does not imply interchangeability.
According to publicly available manufacturer and distributor information, Nucleofill Strong may be used in:
Treatment suitability should be determined by a qualified healthcare professional following clinical assessment.
Deep dermis administration is referenced within publicly available manufacturer documentation.
Not provided by manufacturer.
Supplied with:
Not provided by manufacturer.
Some practitioners utilise multi-session treatment protocols and maintenance schedules; however, these approaches are not included in the manufacturer’s publicly available official IFU guidance.
Nucleofill Strong should only be administered by appropriately trained healthcare professionals using aseptic injection techniques and according to applicable local regulations.
Not provided by manufacturer.
Not applicable.
No lidocaine reported in publicly available product documentation.
Nucleofill Strong is supplied as:
Not provided by manufacturer.
Longevity is not provided by manufacturer in publicly available documentation.
Clinical outcomes vary according to patient factors, treatment area, practitioner technique, and individual biological response.
Publicly available documentation provides limited contraindication information. Standard precautions include:
As with all injectable procedures, appropriate aseptic technique and patient assessment are essential.
UKCA status: verify via current IFU or authorised distributor documentation.
Nucleofill Strong is a high-strength polynucleotide injectable developed for skin bio-restructuring and regenerative aesthetic treatments. It contains 25 mg/ml purified polynucleotides designed to support hydration, tissue quality, and fibroblast activity while helping improve overall skin condition.
The primary difference is concentration. Nucleofill Strong contains 25 mg/ml polynucleotides, while Nucleofill Medium contains 20 mg/ml. The higher concentration provides a stronger regenerative profile and is often selected for patients with more advanced signs of skin ageing or tissue laxity.
No. Nucleofill Strong is a polynucleotide-based injectable and does not rely on hyaluronic acid as its primary active ingredient. Its mechanism focuses on bio-stimulation, hydration support, antioxidant activity, and extracellular matrix enhancement through purified polynucleotides.
The manufacturer does not specify an exact duration of effect in publicly available documentation. Longevity may vary depending on treatment protocol, patient characteristics, skin condition, and maintenance schedules determined by the treating practitioner.
Nucleofill Strong is generally classified as a regenerative injectable skin booster rather than a volumising dermal filler. Its primary purpose is to improve tissue quality, hydration, elasticity, and skin condition rather than providing structural volume replacement.
Let’s talk on WhatsApp